- Home
- KRRO vs CURR Comparison
KRRO vs CURR Comparison
Compare KRRO & CURR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KRRO
- CURR
- Stock Information
- Founded
- KRRO 2014
- CURR 2013
- Country
- KRRO United States
- CURR Singapore
- Employees
- KRRO N/A
- CURR N/A
- Industry
- KRRO Biotechnology: Pharmaceutical Preparations
- CURR Business Services
- Sector
- KRRO Health Care
- CURR Consumer Discretionary
- Exchange
- KRRO Nasdaq
- CURR Nasdaq
- Market Cap
- KRRO 147.4M
- CURR 151.4M
- IPO Year
- KRRO 2019
- CURR N/A
- Fundamental
- Price
- KRRO $30.76
- CURR $1.61
- Analyst Decision
- KRRO Strong Buy
- CURR Strong Buy
- Analyst Count
- KRRO 7
- CURR 1
- Target Price
- KRRO $96.71
- CURR $3.50
- AVG Volume (30 Days)
- KRRO 240.6K
- CURR 223.8K
- Earning Date
- KRRO 11-11-2025
- CURR 08-04-2025
- Dividend Yield
- KRRO N/A
- CURR N/A
- EPS Growth
- KRRO N/A
- CURR N/A
- EPS
- KRRO N/A
- CURR N/A
- Revenue
- KRRO $6,281,000.00
- CURR $41,092,419.00
- Revenue This Year
- KRRO $97.27
- CURR N/A
- Revenue Next Year
- KRRO N/A
- CURR $14.56
- P/E Ratio
- KRRO N/A
- CURR N/A
- Revenue Growth
- KRRO N/A
- CURR N/A
- 52 Week Low
- KRRO $10.29
- CURR $0.33
- 52 Week High
- KRRO $98.00
- CURR $7.08
- Technical
- Relative Strength Index (RSI)
- KRRO 64.76
- CURR 46.17
- Support Level
- KRRO $20.20
- CURR $1.58
- Resistance Level
- KRRO $37.03
- CURR $1.71
- Average True Range (ATR)
- KRRO 3.59
- CURR 0.13
- MACD
- KRRO 0.79
- CURR -0.02
- Stochastic Oscillator
- KRRO 64.15
- CURR 40.77
About KRRO Korro Bio Inc.
Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability.
About CURR Currenc Group Inc. Ordinary Shares
Currenc Group Inc is a fintech pioneer dedicated to transforming financial services through artificial intelligence (AI). It empowers financial institutions with comprehensive AI solutions, including the SEAMLESS AI Call Centre and other AI-powered tools designed to reduce costs, increase efficiency, and boost customer satisfaction. The Company's digital remittance platform also enables e-wallets, remittance companies, and corporations to provide real-time, 24/7 payment services, advancing financial access across underserved communities. It generates the majority of its geographic revenue from Malaysia.